Viral dance challenge lifted Chinese ibuprofen maker’s shares – now they are languishing

South China Morning PostCenter-RightEN 1 min read 100% complete by Julie ZhangFebruary 22, 2026 at 07:00 AM
Viral dance challenge lifted Chinese ibuprofen maker’s shares – now they are languishing

AI Summary

short article 1 min

In late 2022, Shandong Xinhua Pharmaceutical, a leading Chinese ibuprofen maker, experienced a surge in shares due to a viral dance challenge on Douyin inspired by its product packaging. The challenge coincided with China's shift away from its "zero-Covid" policy. However, the company's profits have since declined, with net profit falling 26% year-on-year in the first three quarters of 2025. This downturn follows a 5.3% profit decrease in 2024. Shandong Xinhua attributes the profit decline to price cuts implemented to maintain market share amidst oversupply and weakening demand for fever and pain medications. The company's experience reflects a broader trend affecting drug manufacturers in China.

Keywords

ibuprofen 100% shandong xinhua pharmaceutical 90% profit decline 80% social media 70% pharmaceuticals 70% oversupply 70% weakening demand 70% market share 60% dance challenge 60% covid-19 pandemic 50%

Sentiment Analysis

Negative
Score: -0.30

Source Transparency

Source
South China Morning Post
Political Lean
Center-Right (0.50)
Far LeftCenterFar Right
Classification Confidence
90%
Geographic Perspective
China

This article was automatically classified using rule-based analysis. The political bias score ranges from -1 (far left) to +1 (far right).

Topic Connections

Find Similar Articles

AI-Powered

Discover articles with similar content using semantic similarity analysis.